{"title":"Association of GLP-1 Receptor Agonist Use with Thyroid Outcomes in Adults with Type 2 Diabetes.","authors":"Ching-Chung Hsiao, Ming-Hsien Tsai, Jian-Yu Jhu, Ya-Fang Liu, Chieh-Li Yen, Jia-Jin Chen, Pei-Chi Chen","doi":"10.7150/ijms.141099","DOIUrl":"https://doi.org/10.7150/ijms.141099","url":null,"abstract":"<p><strong>Background: </strong>Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used to treat type 2 diabetes mellitus, but their associations with thyroid disorders remain uncertain. We evaluated whether initiating a GLP-1 RA, compared with initiating a dipeptidyl peptidase-4 inhibitor (DPP-4i), was associated with newly recorded autoimmune thyroiditis and other thyroid outcomes.</p><p><strong>Methods: </strong>This new-user, active-comparator cohort study emulated a target trial using the TriNetX Collaborative Network. Adults with type 2 diabetes who initiated a GLP-1 RA or DPP-4i between January 1, 2018, and December 31, 2022, and had no prior use of either drug class were eligible. Patients with pre-existing thyroid disease, any neoplasm, immunosuppressant or immunostimulant use, transplantation, or end-stage kidney disease or dialysis were excluded. Propensity score matching yielded 107,912 patients per group. The primary outcome was newly recorded autoimmune thyroiditis; secondary outcomes were nontoxic uninodular goiter, nontoxic multinodular goiter, and thyroid malignancy. Cox models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs), with false discovery rate adjustment. Follow-up extended from 1 day after treatment initiation to 4 years.</p><p><strong>Results: </strong>Autoimmune thyroiditis occurred in 524 GLP-1 RA users (0.49%) and 417 DPP-4i users (0.39%). GLP-1 RA initiation was associated with a higher risk of autoimmune thyroiditis (HR, 1.26; 95% CI, 1.11-1.43; FDR-adjusted <i>P</i> = 0.002). Modestly higher risks were also observed for nontoxic uninodular goiter (HR, 1.07; 95% CI, 1.01-1.13) and nontoxic multinodular goiter (HR, 1.11; 95% CI, 1.03-1.19). The risk of thyroid malignancy did not differ significantly (HR, 0.93; 95% CI, 0.77-1.12). Findings were generally consistent across sensitivity and subgroup analyses, although heterogeneity was observed across body mass index strata.</p><p><strong>Conclusion: </strong>Among adults with type 2 diabetes, GLP-1 RA initiation was associated with small increases in newly recorded autoimmune thyroiditis and benign nodular thyroid disease, but not with thyroid malignancy. Given the small absolute differences and the potential for residual confounding and surveillance bias, these findings require validation in future studies.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3494-3505"},"PeriodicalIF":3.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685433/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Erika Čermáková, Monika Kunzová, Jana Olejníčková, Petr Loskot, Martin Forejt
{"title":"Short-Term Changes in Segmental Multi-Frequency Bioelectrical Impedance Measurements Following Water and Banana Intake: A Fixed-Order Within-Subject Study.","authors":"Erika Čermáková, Monika Kunzová, Jana Olejníčková, Petr Loskot, Martin Forejt","doi":"10.7150/ijms.134700","DOIUrl":"https://doi.org/10.7150/ijms.134700","url":null,"abstract":"<p><strong>Background: </strong>Bioelectrical impedance analysis (BIA) is widely used for body composition assessment but may be influenced by hydration status and recent food intake. This study evaluated short-term changes in segmental multi-frequency BIA measurements following water and banana intake.</p><p><strong>Methods: </strong>Ninety-eight healthy adults (54 women, 44 men; 21-33 years) underwent BIA measurements at baseline and at 30, 60, and 90 minutes after consuming 600 mL of water on the first experimental day and 300 g of banana on the second day. The study used a fixed-order within-subject repeated-measures design. Post-ingestion values were analyzed using baseline-adjusted linear mixed-effects models with participant-specific random intercepts. Holm's procedure was applied across the five time × experimental condition/day interaction tests.</p><p><strong>Results: </strong>Significant time × experimental condition/day interactions were not observed for body fat percentage, total body water percentage, or trunk impedance at 20 or 100 kHz (all unadjusted p ≥ 0.133). A significant interaction was observed for visceral fat area estimate (F(2,194) = 8.532, unadjusted p < 0.001; Holm-adjusted p < 0.005). The largest adjusted between-condition/day difference in visceral fat area estimate was 0.858 cm² at 30 minutes. Because intake condition was fixed by study day, condition effects could not be separated from potential day or order effects.</p><p><strong>Conclusions: </strong>Under the fixed-order conditions examined, temporal responses were similar between experimental days for most SMF-BIA outcomes, while a small interaction was observed for visceral fat area estimate. These findings require confirmation in randomized, counterbalanced studies including a no-intake control condition.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3547-3553"},"PeriodicalIF":3.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A naturally occurring polyphenolic compound for liver cancer treatment.","authors":"Ming-Hui Yang, Yu-Chang Tyan, Hsin-Rou Liang, Chia-Yen Dai, Yung-Jen Chuang, Cheng-Hui Yuan, Shih-Chang Chuang","doi":"10.7150/ijms.127785","DOIUrl":"https://doi.org/10.7150/ijms.127785","url":null,"abstract":"<p><p>As a polyphenolic compound naturally found in nature, piceatannol is an analogue of resveratrol. These compounds share a common structural motif but have various substituents. Resveratrol shows anti-inflammation and anti-tumor properties, but such biological activities of the active resveratrol metabolite - piceatannol are unclear. In this study, the anti-tumor properties of piceatannol were investigated through cell viability, colony formation, migration assay, detection of reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) change, reverse transcription quantitative polymerase chain reaction (RT-qPCR), and Western blotting in human hepatocellular carcinoma cell lines. Piceatannol decreased cell viability in a dose-dependent manner. These concentrations required to inhibit 50% of activity (IC<sub>50</sub>) for Huh7, HepG2, and Hep3B cells were 76.1-99.7, 17.0-19.6, and 57.0-83.7 μM after 24-72 hour treatment, respectively. Piceatannol inhibited the abilities of colony-forming and migration of HCC cells. Piceatannol may contribute to cell death in hepatocellular carcinoma cells, accompanied by altered MMP, reduced expression of HSPD1 and increased DNA double strand breaks. Our results show that piceatannol, the metabolite of resveratrol, supports an anti-cancerogenic effect by inhibiting proliferation and promoting cell death. Moreover, piceatannol may be a more potent anticancer agent than resveratrol. Hence, piceatannol could be a candidate for anti-cancer compound for the management of liver cancer.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3531-3546"},"PeriodicalIF":3.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"State-Dependent Decoupling of a CREM-Centric cAMP-Responsive Regulon and Survival in Hepatocellular Carcinoma.","authors":"Hao Ling, Yanzhu Hu","doi":"10.7150/ijms.140851","DOIUrl":"https://doi.org/10.7150/ijms.140851","url":null,"abstract":"<p><strong>Background: </strong>The cAMP-responsive element modulator (CREM) has emerged as a cAMP-responsive transcriptional node associated with dysfunctional lymphocyte states in chronic hepatic infection and some immunosuppressive tumor microenvironments, but its regulatory output and isoform usage by specific cell-types remain insufficiently defined in hepatocellular carcinoma (HCC). Because CREM produces activating isoforms and repressive inducible cAMP early repressor (ICER) isoforms through alternative promoter usage, bulk or single-cell CREM mRNA abundance may not faithfully describe the net direction of downstream CRE-dependent transcriptional programs.</p><p><strong>Methods: </strong>Single-cell RNA-seq datasets spanning 18,665 T cells from two independent, pathologically validated primary liver cancer cohorts (32 HCC and 5 iCCA patients) were integrated, with HCC-only sensitivity analyses confirming the primary findings. Using prior-knowledge transcriptional regulon frameworks cross-referenced with CRE-family genomic occupancy data (ENCODE), CREM mRNA expression was decoupled from its inferred downstream regulon activity at single-cell resolution. Validation was performed using a third-generation long-read direct RNA sequencing hepatic model and bulk TCGA clinical survival cohorts.</p><p><strong>Results: </strong>Across multiple regulon definitions, single-cell CREM mRNA and regulon activity were characterized by prominent low-coupling at the single-cell level (meta-Spearman ρ < 0.20, explaining <4% of variance). Crucially, this low-coupling was not uniform but followed a continuous T-cell state gradient, where the correlation between CREM expression and target activation progressively tightened as T cells transitioned from a resting state toward an activated or exhausted phenotype. Long-read direct RNA sequencing in a hepatic lineage reference model revealed that the activation-associated P1 promoter (CREMτ) predominated over the repressor-associated P2 promoter (ICER) by a 14:1 ratio under steady states. In bulk TCGA-LIHC data, elevated CREM-centric regulon scores, but not raw mRNA levels, correlated with favorable overall survival (HR = 0.787, p = 0.026), operating primarily as a T-cell activation- and infiltration-associated prognostic feature rather than an independent cell-autonomous biomarker.</p><p><strong>Conclusions: </strong>Single-cell CREM mRNA abundance is not a reliable proxy for its transcriptional output in HCC tumor-infiltrating lymphocytes. Instead, the coupling between CREM expression and its regulon activity is dynamically modulated by the T-cell activation state, a phenomenon partially explained by the usage of alternative isoforms in reference models. These findings caution against the routine practice of translating crude transcription factor mRNA metrics directly into functional regulatory inputs within a complex tumor immune microenvironment.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3464-3482"},"PeriodicalIF":3.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685465/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The relationship between 5α-reductase inhibitors and the presence of following open angle glaucoma: a TriNetX cohort study.","authors":"Chia-Yi Lee, Shun-Fa Yang, Shih-Chi Su, Yu-Ling Chang, Jing-Yang Huang, Chao-Bin Yeh, Po-Hsien Huang, Chao-Kai Chang","doi":"10.7150/ijms.137426","DOIUrl":"https://doi.org/10.7150/ijms.137426","url":null,"abstract":"<p><strong>Purpose: </strong>This study was conducted to test a possible association between 5α-reductase inhibitor (5ARI) use and subsequent open-angle glaucoma (OAG).</p><p><strong>Method: </strong>A retrospective cohort study was conducted, and individuals with benign prostate hyperplasia (BPH) and androgenetic alopecia were included and classified according to whether they received 5ARI treatment. A total of 181,208 individuals were included in each of the 5ARI and non-5ARI groups. The primary outcome was the development of OAG according to diagnostic and procedure codes. Cox proportional hazard regression was performed for the statistical analysis.</p><p><strong>Results: </strong>OAG occurred in 3477 patients (5.14%) in the 5ARI group and 3044 patients (4.59%) in the non-5ARI group. After adjustment for multiple covariates, exposure to 5ARIs was associated with a significantly greater risk of OAG compared with the non-5ARI treatment (P < 0.001). The cumulative incidence of OAG was significantly higher among patients receiving 5ARI therapy than among those in the non-5ARI group (P < 0.001), and the cumulative incidence of HTG was significantly higher in the 5ARI population than the non-5ARI population (P = 0.002). In the sensitivity analysis, the 5ARI cohort exhibited significantly increased rates of OAG and HTG compared with the non-5ARI cohort, except for Asian individuals (P > 0.05).</p><p><strong>Conclusions: </strong>The use of 5ARIs may be related to the development of OAG.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3506-3514"},"PeriodicalIF":3.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685435/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Beate Alinger-Scharinger, Georg Hutarew, Christoph Schwartz, Alexander Romagna, Ognian Kalev, Serge Weis, Simon P Gampenrieder, Gabriel Rinnerthaler, Vanessa Castagnaviz, Franz Gassner, Roland Geisberger, Nadja Zaborsky, Richard Greil, Karl Sotlar, Theo F J Kraus
{"title":"Epigenome-Wide DNA Methylation Profiling of Matched Primary Breast Cancers and Brain Metastases Reveals Epigenetic Markers linked to Metastatic Progression: A Preliminary Study.","authors":"Beate Alinger-Scharinger, Georg Hutarew, Christoph Schwartz, Alexander Romagna, Ognian Kalev, Serge Weis, Simon P Gampenrieder, Gabriel Rinnerthaler, Vanessa Castagnaviz, Franz Gassner, Roland Geisberger, Nadja Zaborsky, Richard Greil, Karl Sotlar, Theo F J Kraus","doi":"10.7150/ijms.130407","DOIUrl":"https://doi.org/10.7150/ijms.130407","url":null,"abstract":"<p><strong>Introduction: </strong>Breast cancer represents the most prevalent malignancy among women globally, with a rising incidence of metastases to the central nervous system. The presence of brain metastases is associated with a poor prognosis, largely due to the limited availability of effective treatment modalities.</p><p><strong>Methods: </strong>In this preliminary study, we performed an epigenome-wide DNA-methylation analysis of matched primary breast cancer and brain metastasis of the same patients applying the Illumina Infinium EPIC Bead Chip interrogating more than 850,000 CpG sites at single base resolution.</p><p><strong>Results: </strong>We found that primary breast cancers and corresponding metastases are very similar on the global DNA methylation level. Detailed analysis showed aberrant methylation patterns that reflect the process of brain metastasis. We identified 107 nominally significant methylated CpG sites (DMCGs) within promoter and gene regions (Δβ ≥ 0.1, <i>p</i>-value < 0.05), when comparing primary breast tumors to their brain metastatic counterparts. However, due to the limited sample size, no individual CpG site retained statistically significant after correction for multiple testing.</p><p><strong>Conclusion: </strong>Our study highlights specific aberrant DNA methylation patterns that are associated with brain metastasis in breast cancer. Characterizing these epigenetic alterations provides a promising avenue for identifying novel therapeutic targets and clinically relevant biomarkers.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3554-3564"},"PeriodicalIF":3.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Adolescent and Early-Onset Adenomyosis: Phenotypes, Diagnostic Challenges, and Fertility-Conscious Care.","authors":"Shuhong Yang, Yuling Chen, Xiangyi Ma","doi":"10.7150/ijms.140803","DOIUrl":"https://doi.org/10.7150/ijms.140803","url":null,"abstract":"<p><p>Adolescent and early-onset adenomyosis is increasingly recognized in symptomatic young patients, but its clinical significance remains uncertain. This narrative review synthesizes English-language literature on adolescent and early-onset adenomyosis, distinguishing direct adolescent and young-adult evidence from supportive evidence derived from adult populations. Current data suggest that adenomyosis-like imaging features may be identified in adolescents with severe dysmenorrhea, heavy menstrual bleeding, chronic pelvic pain, or coexisting endometriosis. Early disease often appears as subtle diffuse inner-myometrial change, focal lesions, or cystic/juvenile forms rather than the classic diffuse adult phenotype. Ultrasound is the first-line imaging modality, whereas MRI is reserved for equivocal findings, atypical cystic lesions, suspected congenital anomalies, or endometriosis overlap. Management requires a stepwise, symptom-oriented approach that considers future reproductive options and avoids unnecessary uterine intervention. Overall, adolescent adenomyosis should be considered in patients with severe or treatment-resistant menstrual symptoms, while uncertain imaging findings should not be overinterpreted.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3453-3463"},"PeriodicalIF":3.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hongyuan Chu, Hao Wang, Sijia Wen, Renqiuguo Li, Junjiao Zhang, Fan Zhang, Huaxia Luo, Ye Wu, Jingmin Wang, Kai Gao, Yuwu Jiang
{"title":"The deficiency of <i>htr6</i> gene results in aberrant brain development and epileptiform discharges in zebrafish larvae.","authors":"Hongyuan Chu, Hao Wang, Sijia Wen, Renqiuguo Li, Junjiao Zhang, Fan Zhang, Huaxia Luo, Ye Wu, Jingmin Wang, Kai Gao, Yuwu Jiang","doi":"10.7150/ijms.135746","DOIUrl":"https://doi.org/10.7150/ijms.135746","url":null,"abstract":"<p><strong>Background: </strong>The 5-Hydroxytryptamine Receptor 6 (HTR6) is a G protein-coupled receptor implicated in neurodevelopmental disorders and epilepsy. Our previous studies identified a somatic <i>HTR6</i> mutation in brain surgical specimens from patients with focal cortical dysplasia type II, suggesting its potential involvement in disease pathogenesis.</p><p><strong>Objective: </strong>To investigate the functional role of the <i>htr6</i> in zebrafish, focusing on its impact on neurodevelopment and seizure susceptibility.</p><p><strong>Methods: </strong>A F0 mosaic <i>htr6</i> crispant zebrafish model was generated using CRISPR/Cas9 and validated by sequencing and TIDE analysis. Morphological and central nervous system (CNS) abnormalities were assessed at 5 days post-fertilization (dpf) by bright-field and Tg (HuC: eGFP) fluorescence imaging. Survival was monitored to 21 dpf. Locomotor behavior was evaluated using DanioVision, and epileptiform activity was examined by local field potential recording. Human <i>HTR6</i> mRNA rescue experiments, transcriptome sequencing, and qPCR validation were also performed.</p><p><strong>Results: </strong>Deficiency of <i>htr6</i> resulted in significant reductions in interocular and central nervous system areas. In addition, F0 mosaic <i>htr6</i> crispant showed significantly reduced survival compared with Cas9 controls. While locomotor activity was markedly unaffected, electrophysiological recordings revealed epileptiform events in 9 of 24 F0 mosaic <i>htr6</i> crispant but none in the Cas9 controls. Co-injection of human <i>HTR6</i> mRNA rescued both neurodevelopmental abnormalities and epileptiform activity. Transcriptome analysis identified 402 differentially expressed genes, including the upregulation of 355 and the downregulation of 47 genes, suggesting profound neuronal impacts from <i>htr6</i> deficiency. KEGG pathway enrichment analysis linked these changes to ABC transporters and metabolic pathways, demonstrating the significance of <i>htr6</i> in maintaining neuronal health.</p><p><strong>Conclusion: </strong>Deficiency of <i>htr6</i> in zebrafish results in abnormal brain development and epileptiform activity, underscoring its critical role in neurodevelopment and neuronal excitability. These findings suggest the importance of <i>HTR6</i> in neurodevelopment and epilepsy, providing a foundation for further research on therapeutic strategies targeting <i>HTR6</i>-related pathways in neurological disorders.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3515-3530"},"PeriodicalIF":3.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rosmarinic Acid Enhances Functional Recovery of Injured Muscle via Reducing Fibrosis and Enhancing Muscle Regeneration After Muscle Contusion.","authors":"Yu-Wei Chiang, Hsuan-Ying Chen, Yi-Fu Huang, Cheng-Pu Hsieh","doi":"10.7150/ijms.119669","DOIUrl":"https://doi.org/10.7150/ijms.119669","url":null,"abstract":"<p><p>Muscle contusion is the common injuries and present a challenge in traumatology. Nonsteroidal anti-inflammatory drugs (NSAIDs) relieve inflammation and pain after muscle injury, but the adverse effects including gastrointestinal bleeding and allergy are thorny problems. Therefore, it is imperative to develop safe and effective treatments. Rosmarinic acid (RA), an ester of caffeic acid, is first isolated from rosemary plant. It exhibits various biological activities, but its therapeutic potential on injured muscle remains unclear. In the study, we aimed to explore the effects of rosmarinic acid on skeletal muscle contusion. C57BL/6 mice were randomly assigned to control, injury, injury + diclofenac, and injury + RA groups. The injury of right gastrocnemius muscle was developed using a drop-mass method, and mice received phosphate-buffered saline (PBS), diclofenac (10 mg/kg BW), or rosmarinic acid (40 mg/kg BW) via intraperitoneal administration for 7 or 14 days after injury. Data revealed that rosmarinic acid treatment significantly decreased inflammatory response and collagen deposition in the injured muscles. And, rosmarinic acid treatment attenuated the levels of muscle damage markers (CK, LDH, and GOT) in serum after injury. In the injury + RA group, the levels of desmin, one of known myogenic marker, and the number of centrally nucleated myofibers, which are indicative of regenerating fibers, were both increased in injured muscle on day 7 after injury. Furthermore, rosmarinic acid treatment promoted recovery of locomotor abilities in the behavior analysis. Based on these findings, we suggested that rosmarinic acid treatment mitigated inflammatory responses to protect muscles from further damage, decreased fibrosis, enhanced muscle regeneration, and ultimately improved motor function recovery. Thus, RA may be potential drug for treating contusion-induced muscle injuries.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3483-3493"},"PeriodicalIF":3.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149244547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J Navarro Castellón, I Flores Cacho, Mc López Carrizosa, C Ibáñez Villoslada, M Domínguez Morcillo, E Carrasco Esteban, P Sáez Bueno, Z Zalabarría Zarrabeitia, A Pontes Sanz, N Curiel Pérez, Fj San Miguel Avedillo, M Cámara Gallego, M A Ortega, Ma Sáez García
{"title":"Impact of catheter positioning on planned target volume (PTV) coverage and organs at risk (OARs) in high-dose-rate (HDR) endotracheal brachytherapy: a comparative 2D vs 3D study.","authors":"J Navarro Castellón, I Flores Cacho, Mc López Carrizosa, C Ibáñez Villoslada, M Domínguez Morcillo, E Carrasco Esteban, P Sáez Bueno, Z Zalabarría Zarrabeitia, A Pontes Sanz, N Curiel Pérez, Fj San Miguel Avedillo, M Cámara Gallego, M A Ortega, Ma Sáez García","doi":"10.7150/ijms.136860","DOIUrl":"10.7150/ijms.136860","url":null,"abstract":"<p><strong>Background and purpose: </strong>High-dose-rate endobronchial brachytherapy (HDR-BTE) is an effective technique for the treatment of malignant tracheobronchial tumors. Although two-dimensional (2D) planning provides limited dosimetric information and does not accurately assess the relationship between the catheter and the tumor or the dose delivered to organs at risk (OARs), it continues to be used because it ensures adequate PTV coverage, is associated with low toxicity, and minimizes the risk of catheter displacement by avoiding patient transfer to the CT simulation room.</p><p><strong>Patient and methods: </strong>An 83-year-old patient with 2D HDR-BTE for tracheal recurrence of previously resected lung adenocarcinoma was analyzed and compared with four simulated 3D plans based on catheter position relative to the tumor volume, while keeping the active length and prescribed dose constant.</p><p><strong>Results: </strong>The favorable oblique scenario achieved the best PTV coverage (D90: 9.05 Gy; V100: 100%), although with highest V150 (96.47%) and homogeneity index (IH: 5.14). The unfavorable oblique and posterior positions significantly reduced coverage (V100: 51.4% and 61.29%, respectively). The esophagus was the most sensitive organ, showing the highest doses in the posterior orientation of the catheter. The contralateral lung and heart received low doses; while the aorta showed higher doses in the favorable oblique scenario due to the location of the PTV.</p><p><strong>Conclusions: </strong>Catheter orientation in HDR-BTE has a significant impact on PTV coverage and the dose delivered to critical organs. Despite the trend toward 3D planning, there is no direct clinical evidence comparing the two techniques.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 11","pages":"3432-3439"},"PeriodicalIF":3.7,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149238246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}